Ammonium chloride, also known as NH4Cl, is a widely used compound in the medical field. It is typically used as a buffer, to neutralize acidity in a solution, and as an electrolyte in medical solutions. It is also used in pharmaceuticals, as a preservative and as a stabilizer. Despite its widespread use, the potential of NH4Cl has yet to be fully explored. This article will explore the potential of NH4Cl, looking at its possible applications in medical treatments and other uses.
NH4Cl is a white, crystalline salt, with a molecular weight of 53.49 g/mol and a density of 1.527 g/cm3. It is highly soluble in water, with a solubility of 1.6 g/100 ml, and is also soluble in alcohols and other organic solvents. It is a weak acid, with a pKa of 9.25, and is readily hydrolyzed in water. It is also hygroscopic, meaning it absorbs moisture from the air.
NH4Cl is used in the medical field for a variety of purposes. It is used as a buffer, to neutralize acidity in a solution, and as an electrolyte in medical solutions. It is also used in pharmaceuticals, as a preservative and as a stabilizer. It is also used in the treatment of certain medical conditions, such as hypokalemia, hyperkalemia, and metabolic acidosis.
Despite its widespread use, the potential of NH4Cl has yet to be fully explored. Research has shown that NH4Cl has potential applications in the medical field, such as in the treatment of cancer, as a wound healing agent, and as an anti-inflammatory agent.
Research has shown that NH4Cl may have potential applications in the treatment of cancer. In one study, NH4Cl was found to inhibit the growth of human breast cancer cells in vitro. In another study, NH4Cl was found to inhibit the growth of human liver cancer cells in vitro. The mechanism of action is not yet clear, but it is thought to involve the inhibition of cell proliferation and the induction of apoptosis.
NH4Cl has also been studied for its potential use as a wound healing agent. In one study, NH4Cl was found to improve wound healing in animal models. The mechanism of action is not yet clear, but it is thought to involve the stimulation of collagen synthesis and the promotion of angiogenesis.
NH4Cl has also been studied for its potential use as an anti-inflammatory agent. In one study, NH4Cl was found to reduce inflammation in animal models. The mechanism of action is not yet clear, but it is thought to involve the inhibition of pro-inflammatory cytokines.
NH4Cl is a widely used compound in the medical field, used as a buffer, electrolyte, preservative, and stabilizer. Despite its widespread use, the potential of NH4Cl has yet to be fully explored. Research has shown that NH4Cl may have potential applications in the medical field, such as in the treatment of cancer, as a wound healing agent, and as an anti-inflammatory agent. Further research is needed to explore the potential of NH4Cl in these and other applications.
1.
There has been a recent decrease in the risk of a recurrence of colorectal cancer in stage I to III cases.
2.
In NSCLC, subcutaneous Lazertinib + Amivantamab Dosing Is Not Worse Than IV Dosing.
3.
Recurrent UTIs impact eGFR in children with vesicoureteral reflux
4.
Month-Long Wait Times Caused by US Physician Shortage.
5.
Pharyngoesophageal junction cancer is not a good candidate for endoscopically assisted transoral surgery.
1.
A Closer Look at Poorly Differentiated Carcinoma: Uncovering its Complexities
2.
The Importance of Early Detection in Angiosarcoma: A Story of Survival
3.
Leukemia in Focus: Tools, Trials, and Therapy Strategies for Modern Medical Practice
4.
New Research Advances in the Treatment of Multiple Myeloma and Plasmacytoma
5.
Managing KRAS Inhibitor Toxicities: Focus on Rash and Beyond
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Incidence of Lung Cancer- An Overview to Understand ALK Rearranged NSCLC
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part III
4.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion IV
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation